capAI (LSE:CPAI) has extended its licence and option agreements with R42 Group covering its capMedia platforms Author42, Movie42 and Gamers42, with all arrangements now running until 7 July 2027. The revised agreements extend the exclusive licence periods for Author42 and Movie42, move back the longstop date for Gamers42 and preserve capAI’s option to acquire the intellectual property for each platform at a price of £2 million.
According to the board, the extensions provide additional time to develop, evaluate and commercialise the three artificial intelligence platforms before deciding whether to exercise the acquisition options. The company said the revised timetable supports its disciplined approach to capital allocation by allowing further validation of each platform’s commercial potential before committing to a purchase.
As R42 Group is led by capAI’s executive chairman, the revised agreements were treated as related-party transactions. The amendments were reviewed and approved exclusively by the company’s independent directors, who concluded that the revised terms are fair and reasonable for shareholders who are not connected to the transaction. The decision reflects capAI’s continued focus on maintaining strong corporate governance and protecting shareholder interests.
More about capAI plc
capAI plc is an applied artificial intelligence venture company listed on both the London Stock Exchange and the OTCQB market. Through its capMedia and capMedical businesses, the company develops and commercialises AI-powered products across media, healthcare and digital content markets. Its portfolio includes platforms such as Author42, Movie42 and Gamers42, which are designed to build scalable user bases while following a capital-efficient growth strategy.
Leave a Reply